0000920465-17-000012.txt : 20170106
0000920465-17-000012.hdr.sgml : 20170106
20170106182203
ACCESSION NUMBER: 0000920465-17-000012
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170104
FILED AS OF DATE: 20170106
DATE AS OF CHANGE: 20170106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10182 TELESIS COURT, 6TH FLOOR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 10182 TELESIS COURT, 6TH FLOOR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rolke James
CENTRAL INDEX KEY: 0001693858
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 17515419
MAIL ADDRESS:
STREET 1: 10182 TELESIS COURT, 6TH FLOOR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
wf-form4_148374491099675.xml
FORM 4
X0306
4
2017-01-04
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001693858
Rolke James
10182 TELESIS COURT, 6TH FLOOR
SAN DIEGO
CA
92121
0
1
0
0
Chief Scientific Officer
Stock Option (Right to Buy)
19.19
2017-01-04
4
A
0
64100
0
A
2027-01-04
Common Stock
64100.0
64100
D
This option represents a right to purchase a total of 64,100 shares of the Issuer's Common Stock one quarter of which shall be fully vested and exercisable on January 4, 2018, with the remaining 48,075 shares vesting monthly thereafter over the next three years.
/s/ Ryan Murr, as attorney-in-fact for James Rolke
2017-01-06